Lung-MAP Winter 2020 newsletter
Lung-MAP Winter 2020 Newsletter is Here
December 15, 2020
The Winter 2020 edition of the newsletter on SWOG's Lung-MAP precision medicine trial is out. Lung-MAP is NCI's first precision trial, and tests new treatments for non-small cell cancer in partnership with the National Cancer Institute, Foundation for the National Institutes of Health, and Friends of Cancer Research.
The newsletter gives a grateful accounting of progress made during this remarkable year, with over 900 study registrations. It also also includes links to the latest Lung-MAP manuscript, published in The Lancet Oncology, and a list of new study leaders. Read the newsletter here.
Other Recent Stories
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2025-01/FrontLineHead.Blanke.2022-web-sized_3.png?itok=FR9Odni5)
Jan 31, 2025
Primary results from S1613 in colorectal cancer are now in JCO
![S1613 in JCO](/sites/default/files/styles/news_recent/public/news/2025-01/press-card-S1613-Raghav-725x415_0.png?itok=A2-ULiig)
Jan 29, 2025
When CRC is HER2+, dual HER2 inhibitor may beat standard EGFR inhibitors